Not every early-detection programme starts by inviting people without symptoms for screening. Some begin by improving what happens after someone notices a problem.
WHO’s November 6 account describes a breast-cancer early-diagnosis pilot launched in four regions of Moldova in October 2023. It connected family physicians, regional diagnostic centres, and the national Institute of Oncology through a clearer referral pathway. [Source 1]
According to WHO, the proportion of late-stage diagnoses among patients diagnosed through the programme fell from approximately 36% to 22% in 2024. That is a programme-specific finding. It should not be described as a demonstrated national reduction caused solely by the pilot. [Source 1]
Analysis: make the next step understandable
This is a systems account, not a reconstructed patient story. Its human significance lies in the work required to turn a concern into an assessment.
For someone seeking care, a referral should answer practical questions: where to go, what the receiving service will do, and how the next decision will be communicated. For the services involved, it should establish responsibility when an appointment is missed, information is incomplete, or further testing is needed.
Those are proposed standards for examining a pathway—not independently verified findings about every participating centre.
WHO reports that the pilot also exposed confusion between early diagnosis and screening. Some clinicians systematically examined women without symptoms, generating unnecessary referrals and additional workload. The account describes differences in imaging activity and cancer detection between centres. [Source 1]
That matters because counting procedures alone cannot tell readers whether the right people received the right assessment. A pathway needs measures of timeliness, appropriateness, and completion alongside activity totals.
What remains uncertain
This article reviews WHO’s account rather than the underlying evaluation dataset. It cannot establish how patient selection, comparison periods, or other changes contributed to the reported result. Nor does a change in stage distribution by itself establish a survival benefit.
The experience nevertheless offers a concrete reporting focus: examine what happens between the first concern and a confirmed diagnosis. That work can be made visible without inventing a patient’s journey.
Related on TiPH: Human health · Global health · Global Signal Scan, November 8, 2026 · Latest news